183 related articles for article (PubMed ID: 29608341)
1. Methylene Blue Attenuates Diabetic Retinopathy by Inhibiting NLRP3 Inflammasome Activation in STZ-Induced Diabetic Rats.
Hao J; Zhang H; Yu J; Chen X; Yang L
Ocul Immunol Inflamm; 2019; 27(5):836-843. PubMed ID: 29608341
[No Abstract] [Full Text] [Related]
2. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
5. Palbinone alleviates diabetic retinopathy in STZ-induced rats by inhibiting NLRP3 inflammatory activity.
Shi Q; Wang J; Cheng Y; Dong X; Zhang M; Pei C
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22489. PubMed ID: 32202043
[TBL] [Abstract][Full Text] [Related]
6. The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.
Trotta MC; Maisto R; Guida F; Boccella S; Luongo L; Balta C; D'Amico G; Herman H; Hermenean A; Bucolo C; D'Amico M
PLoS One; 2019; 14(1):e0211005. PubMed ID: 30657794
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice].
Li B; Zhang DC; Li XW; Dong XN; Li WP; Li WZ
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):476-483. PubMed ID: 35178992
[TBL] [Abstract][Full Text] [Related]
9. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
Kuo CY; Maran JJ; Jamieson EG; Rupenthal ID; Murphy R; Mugisho OO
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430950
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation.
Li S; Yang H; Chen X
Exp Anim; 2019 May; 68(2):221-231. PubMed ID: 30606939
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
12. MiR-30a Regulates S100A12-induced Retinal Microglial Activation and Inflammation by Targeting NLRP3.
Dong N; Wang Y
Curr Eye Res; 2019 Nov; 44(11):1236-1243. PubMed ID: 31199706
[No Abstract] [Full Text] [Related]
13. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway.
Amin FM; Abdelaziz RR; Hamed MF; Nader MA; Shehatou GSG
Life Sci; 2020 Sep; 256():117887. PubMed ID: 32497629
[TBL] [Abstract][Full Text] [Related]
15. [Insulin promotes BAMBI expression and inhibits inflammation in renal cortex of diabetic rats].
Liang D; Peng C; Xiao Y; Pan X; Li Z; Xiao Y; Tian C; Zhang F; Guo B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Feb; 36(2):104-110. PubMed ID: 32314706
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of TSPO-VDAC complex is correlated with NLRP3 inflammasome activation in diabetic retinopathy.
Guo Y; Sun Z; Wang L; Jiang R; Shu Q; Xu G
Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36205135
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
20. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
